270 related articles for article (PubMed ID: 34913774)
1. High diagnostic value of miRNAs for NSCLC: quantitative analysis for both single and combined miRNAs in lung cancer.
Yi M; Liao Z; Deng L; Xu L; Tan Y; Liu K; Chen Z; Zhang Y
Ann Med; 2021 Dec; 53(1):2178-2193. PubMed ID: 34913774
[TBL] [Abstract][Full Text] [Related]
2. The potential diagnostic value of extracellular vesicle miRNA for human non-small cell lung cancer: a systematic review and meta-analysis.
Huang H; Zhu J; Lin Y; Zhang Z; Liu J; Wang C; Wu H; Zou T
Expert Rev Mol Diagn; 2021 Aug; 21(8):823-836. PubMed ID: 34043929
[No Abstract] [Full Text] [Related]
3. The Accuracy of Single MicroRNAs in Peripheral Blood to Diagnose Ovarian Cancer: An Updated Meta-Analysis.
Cui Y; Hong S; Zhu X
Dis Markers; 2020; 2020():1075942. PubMed ID: 32025275
[TBL] [Abstract][Full Text] [Related]
4. Clinically Correlated MicroRNAs in the Diagnosis of Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.
Jiang M; Li X; Quan X; Li X; Zhou B
Biomed Res Int; 2018; 2018():5930951. PubMed ID: 30050938
[No Abstract] [Full Text] [Related]
5. Serum microRNA Signature Is Capable of Early Diagnosis for Non-Small Cell Lung Cancer.
Yang X; Zhang Q; Zhang M; Su W; Wang Z; Li Y; Zhang J; Beer DG; Yang S; Chen G
Int J Biol Sci; 2019; 15(8):1712-1722. PubMed ID: 31360113
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of diagnostic and prognostic value of miR-126 in non-small cell lung cancer.
Sun L; Zhou H; Yang Y; Chen J; Wang Y; She M; Li C
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32329507
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and Prognostic Value of miRNAs in Hepatoblastoma: A Systematic Review With Meta-Analysis.
Wu B; Zhen K; Guo L; Sun C
Technol Cancer Res Treat; 2022; 21():15330338221087830. PubMed ID: 35532186
[No Abstract] [Full Text] [Related]
8. A comprehensive analysis of microRNAs as diagnostic biomarkers for asthma.
Xu L; Yi M; Tan Y; Yi Z; Zhang Y
Ther Adv Respir Dis; 2020; 14():1753466620981863. PubMed ID: 33357010
[TBL] [Abstract][Full Text] [Related]
9. The value of miR-155 as a biomarker for the diagnosis and prognosis of lung cancer: a systematic review with meta-analysis.
Shao C; Yang F; Qin Z; Jing X; Shu Y; Shen H
BMC Cancer; 2019 Nov; 19(1):1103. PubMed ID: 31727002
[TBL] [Abstract][Full Text] [Related]
10. MicroRNAs in body fluids as biomarkers for non-small cell lung cancer: a systematic review.
Huang Y; Hu Q; Deng Z; Hang Y; Wang J; Wang K
Technol Cancer Res Treat; 2014 Jun; 13(3):277-87. PubMed ID: 24066954
[TBL] [Abstract][Full Text] [Related]
11. Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer.
Geng Q; Fan T; Zhang B; Wang W; Xu Y; Hu H
Respir Res; 2014 Nov; 15(1):149. PubMed ID: 25421010
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs as novel biomarkers in the diagnosis of non-small cell lung cancer: a meta-analysis based on 20 studies.
Chen L; Jin H
Tumour Biol; 2014 Sep; 35(9):9119-29. PubMed ID: 25027397
[TBL] [Abstract][Full Text] [Related]
13. Significance of Serum MicroRNAs in the Auxiliary Diagnosis of Non-Small Cell Lung Cancer.
Shi GL; Chen Y; Sun Y; Yin YJ; Song CX
Clin Lab; 2017 Jan; 63(1):133-140. PubMed ID: 28164492
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer.
Zhu W; Zhou K; Zha Y; Chen D; He J; Ma H; Liu X; Le H; Zhang Y
PLoS One; 2016; 11(4):e0153046. PubMed ID: 27093275
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs as ideal biomarkers for the diagnosis of lung cancer.
Guo Z; Zhao C; Wang Z
Tumour Biol; 2014 Oct; 35(10):10395-407. PubMed ID: 25053595
[TBL] [Abstract][Full Text] [Related]
16. Potential circulating miRNA signature for early detection of NSCLC.
Arab A; Karimipoor M; Irani S; Kiani A; Zeinali S; Tafsiri E; Sheikhy K
Cancer Genet; 2017 Oct; 216-217():150-158. PubMed ID: 29025589
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs in sputum specimen as noninvasive biomarkers for the diagnosis of nonsmall cell lung cancer: An updated meta-analysis.
Zhang X; Wang Q; Zhang S
Medicine (Baltimore); 2019 Feb; 98(6):e14337. PubMed ID: 30732158
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of microRNAs as potential biomarkers in circulating HPV-DNA-positive non-small cell lung cancer patients.
Wu Y; Yin Q; Zhou YL; He L; Zou ZQ; Dai XY; Xia W
Cancer Biol Ther; 2021 Feb; 22(2):136-148. PubMed ID: 33535877
[TBL] [Abstract][Full Text] [Related]
19. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
[TBL] [Abstract][Full Text] [Related]
20. Identification of serum MiRNAs as candidate biomarkers for non-small cell lung cancer diagnosis.
Zhang X; Tan J; Chen Y; Ma S; Bai W; Peng Y; Shi G
BMC Pulm Med; 2022 Dec; 22(1):479. PubMed ID: 36522766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
